Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elanco Animal Health IncELAN · Entity 3457 | SEE REMARKS | March 02, 2023 | March 06, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elanco Animal Health Inc
Report date March 02, 2023 · Filed March 06, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 133,294 |
Ending reported balance
After 2023-03-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-03-02 · Grant · Acquired 33,502 · Balance 147,885 Row 2 · 2023-03-02 · Tax withholding · Disposed 14,591 · Balance 133,294 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2023 Filed Mar 4, 2023 02:08 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 970 | $11.01 | $10,679.70 |
DisclosureSEC source: 0001415889-23-004287 · form4-03042023_020319.xml · nonDerivative · entry 3 Urbanek David Alan · CIK 0001752446 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,383 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. F3 · balance_after: Balance reflects 659 fewer shares due to an error in the number of shares previously reported as forfeited in a prior Form 4. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 23:52 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 14,591 | $11.01 | $160,646.91 |
DisclosureSEC source: 0001415889-23-004356 · form4-03062023_110307.xml · nonDerivative · entry 2 Urbanek David Alan · CIK 0001752446 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,294 Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 23:52 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 33,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004356 · form4-03062023_110307.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,885 Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:08 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option (right to buy) · Derivative | 60,700 | $0.00 Strike: $11.26 | $0.00 |
DisclosureSEC source: 0001415889-23-004287 · form4-03042023_020319.xml · derivative · entry 4 Urbanek David Alan · CIK 0001752446 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,700 Underlying: Common Stock · 60,700 shares Expires 2033-03-01 F4 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:08 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 26,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004287 · form4-03042023_020319.xml · nonDerivative · entry 2 Urbanek David Alan · CIK 0001752446 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,012 F2 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:08 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 2,923 | $11.26 | $32,912.98 |
DisclosureSEC source: 0001415889-23-004287 · form4-03042023_020319.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,435 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 01:59 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 961 | $29.00 | $27,869.00 |
DisclosureSEC source: 0001415889-22-002468 · form4-03032022_050327.xml · nonDerivative · entry 3 Urbanek David Alan · CIK 0001752446 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,358 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:59 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option(right to buy) · Derivative | 27,480 | $0.00 Strike: $28.94 | $0.00 |
DisclosureSEC source: 0001415889-22-002468 · form4-03032022_050327.xml · derivative · entry 4 Urbanek David Alan · CIK 0001752446 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,480 Underlying: Common Stock · 27,480 shares Expires 2032-03-01 F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:59 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 1,800 | $28.94 | $52,092.00 |
DisclosureSEC source: 0001415889-22-002468 · form4-03032022_050327.xml · nonDerivative · entry 2 Urbanek David Alan · CIK 0001752446 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,319 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:59 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 10,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002468 · form4-03032022_050327.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,119 F1 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2022, one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:40 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 10,305 | $25.98 | $267,723.90 |
DisclosureSEC source: 0001179110-22-001596 · edgar.xml · nonDerivative · entry 2 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,778 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:40 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 24,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001596 · edgar.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,083 F1 · price: Vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan. Read SEC document |
| October 20, 2021 Filed Oct 22, 2021 20:22 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 3,042 | $33.66 | $102,393.72 |
DisclosureSEC source: 0001179110-21-009593 · edgar.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,242 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 23:31 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 630 | $32.34 | $20,374.20 |
DisclosureSEC source: 0000950138-21-000168 · edgar.xml · nonDerivative · entry 3 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,284 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:31 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 425 | $33.65 | $14,301.25 |
DisclosureSEC source: 0000950138-21-000168 · edgar.xml · nonDerivative · entry 2 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,914 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:31 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 7,876 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-21-000168 · edgar.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,339 F1 · price: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 1, 2021, one-third vesting on March 1, 2022, one-third vesting on March 1, 2023, and the remaining vesting on March 1, 2024. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 23:01 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 3,406 | $30.58 | $104,155.48 |
DisclosureSEC source: 0000950138-21-000154 · edgar.xml · nonDerivative · entry 2 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,463 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 23:01 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 11,916 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-21-000154 · edgar.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,869 F1 · price: Vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 22:23 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 6,636 | $30.67 | $203,526.12 |
DisclosureSEC source: 0000950138-21-000016 · edgar.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,953 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 23:41 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 2,823 | $28.77 | $81,217.71 |
DisclosureSEC source: 0000950138-20-000366 · edgar.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,589 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:54 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 6,678 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000132 · edgar.xml · nonDerivative · entry 2 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,412 F2 · price: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 2, 2020, one-third vesting on March 2, 2021, one-third vesting on March 2, 2022, and the remaining vesting on March 2, 2023. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 22:54 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 425 | $27.40 | $11,645.00 |
DisclosureSEC source: 0000950138-20-000132 · edgar.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,734 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 22:14 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 5,095 | $30.98 | $157,843.10 |
DisclosureSEC source: 0000950138-20-000097 · edgar.xml · nonDerivative · entry 2 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,159 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 22:14 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 17,887 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000097 · edgar.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,254 F1 · price: Vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:40 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 1,066 | $29.45 | $31,393.70 |
DisclosureSEC source: 0000950138-20-000006 · edgar.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,367 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 22:01 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 76 | $26.29 | $1,997.96 |
DisclosureSEC source: 0000950138-19-000545 · edgar.xml · nonDerivative · entry 4 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 76 F1 · shares: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 22:01 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 76 | $26.27 | $1,996.25 |
DisclosureSEC source: 0000950138-19-000545 · edgar.xml · nonDerivative · entry 3 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 76 F1 · shares: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 22:01 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 76 | $26.21 | $1,991.94 |
DisclosureSEC source: 0000950138-19-000545 · edgar.xml · nonDerivative · entry 2 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 76 F1 · shares: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 21:56 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 35,433 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000142 · edgar.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,433 F1 · shares: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 12, 2019, with 3,144 vesting on December 31, 2019, 9,876 vesting on September 1, 2020, and 22,413 vesting on December 31, 2020. Awards issued in replacement of previously held awards with respect to shares of common stock of Eli Lilly & Company (Lilly), which were forfeited in connection with the completion of an exchange offer on March 11, 2019 by Lilly, in which Lilly disposed of all of Elanco's shares held by it. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 22:10 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 2,021 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950138-19-000139 · edgar.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 F1 · price: On March 11, 2019, Eli Lilly and Company ("Lilly") announced the completion of its offer to exchange shares of Lilly common stock for all of the common stock of the Issuer owned by Lilly (the "Exchange Offer"). The Reporting Person tendered 3,294 shares of Lilly common stock in the Exchange Offer, which shares were subject to a proration factor of 13.5970839%. As a result, the Reporting Person received 2,021 shares of Issuer common stock in exchange for 448 shares of Lilly common stock accepted in the Exchange Offer, based on an exchange ratio of 4.5121 shares of Issuer common stock for each share of Lilly common stock accepted. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:09 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000123 · edgar.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,979 F1 · shares: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 1, 2019, one-third vesting on March 1, 2020, one-third vesting on March 1, 2021, and the remaining vesting on March 1, 2022. Read SEC document |
| October 20, 2018 Filed Oct 23, 2018 23:22 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantNon-Qualified Stock Option (Right-to-Buy) · Derivative | 21,086 | Not disclosed Strike: $31.61 | Not disclosed |
DisclosureSEC source: 0000950138-18-000574 · edgar.xml · derivative · entry 2 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,086 Underlying: Elanco Animal Health Inc. Common Stock · 21,086 shares Expires 2028-10-20 F2 · price: Grant of stock option pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021. F2 · derivative.exercise_date: Grant of stock option pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021. Read SEC document |
| October 20, 2018 Filed Oct 23, 2018 23:22 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 6,979 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-18-000574 · edgar.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,479 F1 · shares: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 20:20 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 500 | $24.00 | $12,000.00 |
DisclosureSEC source: 0001140361-18-039155 · form4.xml · nonDerivative · entry 1 Urbanek David Alan · CIK 0001752446 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.